ATE325889T1 - Screening-verfahren - Google Patents

Screening-verfahren

Info

Publication number
ATE325889T1
ATE325889T1 AT01947681T AT01947681T ATE325889T1 AT E325889 T1 ATE325889 T1 AT E325889T1 AT 01947681 T AT01947681 T AT 01947681T AT 01947681 T AT01947681 T AT 01947681T AT E325889 T1 ATE325889 T1 AT E325889T1
Authority
AT
Austria
Prior art keywords
cell
apoptopic
exposing
identifying
state
Prior art date
Application number
AT01947681T
Other languages
English (en)
Inventor
Tom Cotter
Ian Hayes
Finbarr Murphy
Liam Seery
Original Assignee
Eirx Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0016692.6A external-priority patent/GB0016692D0/en
Application filed by Eirx Therapeutics Ltd filed Critical Eirx Therapeutics Ltd
Application granted granted Critical
Publication of ATE325889T1 publication Critical patent/ATE325889T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ecology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01947681T 2000-07-07 2001-07-09 Screening-verfahren ATE325889T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016692.6A GB0016692D0 (en) 2000-07-07 2000-07-07 Method
US25445900P 2000-12-08 2000-12-08

Publications (1)

Publication Number Publication Date
ATE325889T1 true ATE325889T1 (de) 2006-06-15

Family

ID=26244614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01947681T ATE325889T1 (de) 2000-07-07 2001-07-09 Screening-verfahren

Country Status (5)

Country Link
EP (1) EP1299558B1 (de)
AT (1) ATE325889T1 (de)
AU (1) AU2001269326A1 (de)
DE (1) DE60119524T2 (de)
WO (1) WO2002004657A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003054010A2 (en) * 2001-12-20 2003-07-03 Eirx Therapeutics Limited Early stage redox-related apoptosis modulator-2 (esram-2)
JP2006518590A (ja) * 2003-01-23 2006-08-17 アイルクス セラピューティクス リミテッド アポトーシスに関与するキナーゼおよびｇｐｃｒ
GB0305267D0 (en) * 2003-03-07 2003-04-09 Eirx Therapeutics Ltd Proteins involved in apoptosis
CA2612224A1 (en) * 2005-06-20 2007-01-04 Exelixis, Inc. Galk1s as modifiers of the pten/akt pathway and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0926242A1 (de) * 1996-12-02 1999-06-30 Ajinomoto Co., Inc. Gliotoxin-derivate und ein sie enthaltendes antikrebsmittel.
AU765741B2 (en) * 1997-12-19 2003-09-25 Warner-Lambert Company Sag: sensitive to apoptosis gene

Also Published As

Publication number Publication date
DE60119524D1 (de) 2006-06-14
AU2001269326A1 (en) 2002-01-21
WO2002004657A2 (en) 2002-01-17
DE60119524T2 (de) 2007-05-03
EP1299558B1 (de) 2006-05-10
WO2002004657A3 (en) 2003-01-16
EP1299558A2 (de) 2003-04-09

Similar Documents

Publication Publication Date Title
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
NO990338D0 (no) Celleadhesjonsinhibitorer
ATE302983T1 (de) Verfahren zur überwachung von dokumenten
DK0906333T3 (da) Substrater og inhibitorer for proteolytiske enzymer
ATE290208T1 (de) Vorrichtung und verfahren zur ausführung elektrischer messungen an gegenständen
ATE330032T1 (de) Verfahren zur erhaltung der dns-integrität
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
DE69532813D1 (de) Inhibitor der stammzellenproliferation und dessen verwendung
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
DK1554638T3 (da) Fremgangsmåde til at overvåge og analysere en proces
ATE325889T1 (de) Screening-verfahren
HK1064441A1 (en) Method of determining a remaining operating time of a potentiometric measuring probe, apparatus for performing the method, and use of the apparatus
IL173850A0 (en) Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production method
DE60334499D1 (de) Verfahren zur erhöhung der ausbreitung von b-zellen
ATE457371T1 (de) Verfahren und vorrichtung zum magnetronsputtern
ATE423129T1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
DK1385993T3 (da) Fremgangsmåde til detektering og behandling af tuberøs sclerose kompleksrelaterede lidelser
DE50105206D1 (de) Verfahren zum selektieren von inhibitoren für enzyme
ATE346957T1 (de) Verfahren zum nachweis von chloralhydrat in dichloressigsäure
ATE343002T1 (de) Verfahren zur isolation des 20s proteasoms, und verfahren zur identifikation von inhibitoren des 20s und 26s proteasoms
ITPI20010054A0 (it) Metodo e apparecchiatura per caricamento su forme di calzini, gambaletti e simili
DE60320844D1 (de) Kristallstruktur der glutamatracemase (muri)
WO2003106385A3 (en) METHOD FOR SCREENING FUNGITOXIC COMPOUNDS
NO20050919L (no) Fremgangsmate for identifisering av stoffer
IS7441A (is) Peptíðdeformýlasatálmar

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties